Remed stock price
리메드KRX:302550 · KOSDAQ · HealthcareToday's signals · No active technical signal.
Signal details →Remed last closed at ₩2,635 (+0.76%) on 2026-10-02. Listed on KOSDAQ. Trailing 12 months PER is 39.2×. Its overall grade ranks 87 of 306 stocks in Healthcare.
About this company
Remed last closed at ₩2,635 (+0.76%) on 2026-10-02. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall A- · 87/306
Valuation grade D
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 삼성바이오로직스Customer
메디컬·바이오 생산/연구 관련 장비·서비스 수요처로 연결 가능성이 큼
- 셀트리온Customer
바이오의약품 관련 설비·연구 장비 수요 측면의 주요 고객 후보
- SK바이오사이언스Customer
바이오 연구·생산 인프라와 연관된 주요 수요처로 볼 수 있음
About Remed
- What technical signals does Remed (302550) have?
- Remed current technical signals: no active technical signal.
- Is Remed a cup-and-handle pattern?
- No. Remed has no valid Cup signal right now.
- What published figures are available for Remed?
- Market cap: KRW 82.99B. Trailing 12 months PER: 39.2×. Latest quarter PBR: 2.10×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Remed, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).